Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine and Ketamine vs Oral Chloral Hydrate for Pediatric Sedation
NCT04820205Completed
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine and ketamine in Procedural sedation (PS) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Success rate of adequate sedation (PSSS= 1,2,3) within 15 minutes. Started Oct 2021; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT04820205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04820205.